tiprankstipranks
Trending News
More News >
IPH Ltd. (AU:IPH)
ASX:IPH

IPH Ltd. (IPH) AI Stock Analysis

Compare
111 Followers

Top Page

AU:IPH

IPH Ltd.

(Sydney:IPH)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
AU$4.50
â–²(21.95% Upside)
Action:UpgradedDate:02/20/26
The score is driven primarily by solid financial performance (notably strong cash flow) and attractive valuation (low P/E and high dividend yield). Offsetting factors include mixed technical signals and earnings-call risks tied to ANZ softness and uncertainty around the timing of the Canadian CIPO backlog unwind.
Positive Factors
Strong cash generation
Consistent FCF growth and strong cash conversion provide durable funding for dividends, buybacks, debt reduction and targeted investments. Reliable cash generation cushions earnings volatility from filing cycles and supports capital allocation priorities without relying on external financing.
Market leadership and global footprint
Leading positions across key jurisdictions and a multi‑brand, multi‑jurisdiction platform drive referral flows, cross‑selling and pricing leverage. Geographic diversification reduces single‑market risk and supports durable revenue streams from multinational clients and recurring prosecution work.
Canada turnaround and acquisition synergies
A material operational recovery in Canada and successful integration of acquisitions increased scale, recurring filings and profitability. Canada now contributes over one‑third of group earnings, strengthening the group's revenue base and providing structural growth optionality as filing volumes normalize.
Negative Factors
ANZ revenue and earnings decline
Significant exposure to U.S. PCT originated work has structurally reduced ANZ fee pools and margins. Sustained lower PCT volumes or slow re‑diversification would compress group earnings and weaken a historically important regional profit contributor over the medium term.
Canada CIPO backlog and timing uncertainty
A services‑process backlog at the Canadian patent office delays revenue recognition and makes filing throughput lumpy. Until the backlog reliably unwinds, revenue and cash flow visibility from a key growth market remain impaired, limiting near‑term predictability despite long‑term potential.
Higher tax rate and margin pressure
An elevated effective tax rate combined with declining net margins reduces the proportion of revenue converting to owner earnings. This structural compression limits reinvestment capacity and cash available for distributions, making returns more sensitive to slower revenue or margin headwinds.

IPH Ltd. (IPH) vs. iShares MSCI Australia ETF (EWA)

IPH Ltd. Business Overview & Revenue Model

Company DescriptionIPH Limited, together with its subsidiaries, provides intellectual property (IP) services and products in Australia and internationally. It operates through three segments: Intellectual Property Services Australia & New Zealand, Intellectual Property Services Asia, and Adjacent Businesses. The company offers IP services related to the provision of filing, prosecution, enforcement, and management of patents, designs, trademarks, and other IP; and develops autonomous timekeeping software under the subscription license model. It also provides patent attorney, lawyers, support, and data analysis services. The company serves Fortune Global 500 companies, multinationals, public sector research organizations, SMEs, professional services firms, universities, foreign associates, and other corporate and individual clients. IPH Limited was founded in 1887 and is based in Sydney, Australia.
How the Company Makes MoneyIPH generates revenue through several key streams, primarily from its IP services such as patent and trademark filing, prosecution, and maintenance services. The company charges fees for its services, which vary based on the complexity and type of IP being managed. Additionally, IPH earns revenue from its subsidiaries and associated firms that specialize in various aspects of IP management, thus broadening its service offerings and client base. Strategic partnerships with law firms and technology companies enhance its market reach and contribute to its earnings. The firm also benefits from ongoing maintenance fees for existing IP rights, creating a recurring revenue model. Overall, IPH's diversified service portfolio and established relationships in the IP sector are significant factors that support its financial performance.

IPH Ltd. Earnings Call Summary

Earnings Call Date:Feb 19, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Aug 26, 2026
Earnings Call Sentiment Positive
The call presented a predominantly positive operational and financial picture: group revenue and underlying EBITDA grew, statutory profit rose double‑digits, cash conversion remained strong and management increased dividends while reducing net debt. Canada delivered a standout turnaround and Asia returned to growth, driven by higher filings and case transfers. However, material near‑term headwinds persist—ANZ earnings were down due to lower U.S. PCT volumes, the CIPO backlog in Canada has not yet cleared (creating delayed revenue), and tax and FX translation effects compressed some metrics. Management’s cost discipline, balance sheet strength, AI adoption and successful acquisitions mitigate these risks and support confidence in medium‑term recovery.
Q2-2026 Updates
Positive Updates
Group Revenue Growth
Total revenue of $363.9 million, up 6.5% year‑on‑year, driven by incremental contribution from the Bereskin & Parr acquisition and organic growth in Canada and Asia.
Underlying EBITDA and Profit Improvements
Underlying EBITDA increased 6.6% to $107.1 million. Statutory net profit after tax rose 10.5%, and underlying NPATA increased 2.6% to $62.6 million.
Strong Cash Generation and Dividend
Gross operating cash flow to EBITDA conversion of 101% with free cash flow up 32%. Interim dividend increased 11.8% to $0.19 per share (20% franked) and represents a payout ratio of 81% of cash adjusted NPAT.
Canada: Major Turnaround and Scale
Canada delivered a strong turnaround: like‑for‑like underlying EBITDA up 18.9% and like‑for‑like revenue up 7.3%. Canada now accounts for over one‑third of group earnings; annualized run rate based on H1: ~$323 million revenue and EBITDA >$83 million, with annualized patent filings >10,000. Acquisition synergies from Bereskin & Parr achieved.
Asia Returning to Growth
Asia like‑for‑like revenue +3.5% and underlying EBITDA +1.5%. Filings ex Singapore up 7.3%. Strong country-level gains: Hong Kong patent filings +37%, Vietnam +21%, Philippines +26%, Brunei +57% (low base). Over 2,200 case transfers into Asia (1,500+ trademarks, 500+ patents, 200 designs).
Market Leadership and Network Strength
Company maintains #1 patent group positions in Australia, Canada, Singapore and New Zealand; #1 filer in Indonesia. Global scale (7 brands, ~1,700 employees across ~26 IP jurisdictions) supports resilience and cross-jurisdiction referrals.
Client Referrals and Case Transfers
Nearly 1,200 cumulative client referrals between IPH Canada and Asia since 2022; referral volume almost doubled in the last 12 months. Recent wins include ~100 patent case transfers to Southeast Asia/China/Australia and ~500 patent case transfer into ANZ in recent months.
Cost Discipline and Corporate Savings
Corporate costs reduced by $2.5 million in H1, underlying EBITDA margin lifted modestly (+0.1 percentage points). FY'25 cost realignment and ongoing discipline contributed to improved margins.
Balance Sheet and Capital Management
Net debt reduced by 6.5% (~$27 million) to a leverage ratio of 1.8x (down from 1.9x) within target up to 2x. Group refinanced $210 million of syndicated debt on improved pricing; undrawn facilities of $111 million. Announced on‑market buyback program (up to 12.2 million shares).
Operational Efficiency and Technology Adoption
Low capex (H1 $1.5 million vs prior $6.1 million). Active embedding of AI and automation across patent drafting, prosecution and administrative workflows to streamline operations and reduce costs.
Negative Updates
ANZ Revenue and Earnings Decline
ANZ like‑for‑like revenue down 6.1% and underlying EBITDA down 10.6%, reflecting disproportionate exposure to a decline in U.S. PCT filings. Australian patent market decreased 12.9% for the half with IPH filings down 5.4% (normalized excluding self‑filed applications: IPH -4.8% vs market +1.9%).
CIPO Backlog and Timing Uncertainty
Canada continues to face a backlog at the Canadian Intellectual Property Office (CIPO) following a July 2024 systems upgrade; no meaningful clearance yet. The backlog represents delayed revenue (timing of unwind uncertain; management hopes for calendar 2026 but not confirmed).
Higher Effective Tax Rate Post‑Acquisition
Underlying effective tax rate increased from 20.4% to 26.2% following Canadian acquisition activity, and management expects this normalized (higher) rate going forward based on geographic earnings mix.
Margin Pressure in ANZ and Employee Costs
Margin reduction in ANZ tempered group margin gains. Employee benefits expense increased 6.8%, primarily reflecting acquisition impact, though offset partially by cost reduction programs.
Singapore Market Weakness and Client Concentration
Singapore patent filing market declined by 8.6% (YTD to Nov); IPH filings down 13.9% (noting one large client materially reduced filings—normalized IPH decline ~10%). Client concentration risks persist in some markets.
Foreign Exchange and Translation Impacts
Group recorded a net FX loss of $0.2 million (vs prior $1.3 million gain). Foreign currency translation reserve fell $14.1 million; intangible assets reduced ~$19.1 million due to FX translation—these moves compressed some balance sheet metrics.
Non‑Underlying and Transformation Costs
H1 non‑underlying expenses (net of tax) were $2.8 million related to transformation projects and IT implementation, signaling ongoing investment and one‑off costs despite being lower than prior period ($4.8 million).
Risk from Self‑Filed / AI‑Generated Applications
Surge in self‑filed/AI‑generated provisional applications in Australia may reduce upfront filing revenue pools for firms that target those low‑margin volumes. Management views this as limited immediate threat to IPH’s secondary‑market focus but flags it as an industry risk.
Timing and Exposure Risks in ANZ and US Filings
Significant exposure remains to U.S. origin filings (estimated ~30–35% of Australian market for IPH). Recovery depends on U.S. PCT trends and successful re‑diversification into Europe, Japan, Korea and China—outcomes uncertain.
Company Guidance
Management guided that FY‑26 priorities are to leverage Canada’s integrated platform to capture the expected (timing uncertain but anticipated in calendar 2026) unwind of the CIPO backlog, to capitalise on Asia’s return to growth and >2,200 recent case transfers (including ~1,500 trademarks, ~500 patents, ~200 designs), and to re‑target ANZ business development away from U.S. PCTs toward Western Europe, Japan, South Korea and Chinese incoming filings. They reiterated a focus on operational efficiencies and AI automation (corporate costs down $2.5m in H1) after delivering H1 revenue $363.9m (+6.5%), underlying EBITDA $107.1m (+6.6%), underlying NPATA $62.6m (+2.6%), like‑for‑like revenue +0.7% and like‑for‑like EBITDA +3.2% (margin +0.7ppt); segment metrics included Canada like‑for‑like EBITDA +18.9% (margin +2.6ppt), Asia filings ex‑Singapore +7.3% (Asia LFL revenue +3.5%, EBITDA +1.5%), and ANZ LFL revenue −6.1% / EBITDA −10.6% (Australian market −12.9%, IPH −5.4% or −4.8% excl. self‑filed AI provisionals). Balance‑sheet/capital guidance: cash conversion 101%, free cash flow +32%, interim dividend +11.8% to $0.19 (franked 20%, payout 81% of cash‑adjusted NPAT), net debt −6.5%, leverage 1.8x (target ≤2x), $111m undrawn facilities, $210m refinanced facility, and an on‑market buyback up to 12.2m shares.

IPH Ltd. Financial Statement Overview

Summary
Solid fundamentals supported by strong cash generation (free cash flow growth 10.82%, good cash conversion) and steady revenue growth, offset by modest profitability/margin erosion and remaining leverage risk despite improvement.
Income Statement
78
Positive
IPH Ltd. has demonstrated consistent revenue growth, with a 4.82% increase in the latest year. The gross profit margin remains strong at 100%, indicating effective cost management. However, the net profit margin has slightly decreased to 9.74%, suggesting increased expenses or other financial pressures. EBIT and EBITDA margins have also declined, pointing to potential operational challenges.
Balance Sheet
72
Positive
The company's debt-to-equity ratio has improved to 0.67, reflecting better leverage management. Return on equity is stable at 9.84%, indicating efficient use of equity. The equity ratio is healthy, suggesting a solid financial foundation. However, the overall leverage remains a concern, which could pose risks if not managed carefully.
Cash Flow
80
Positive
IPH Ltd. has shown a robust free cash flow growth of 10.82%, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is 1.31, indicating good cash conversion. The free cash flow to net income ratio of 0.94 suggests efficient cash utilization. These metrics reflect a strong cash flow position, supporting future investments and debt servicing.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue728.50M706.20M605.60M482.87M374.33M359.68M
Gross Profit489.30M706.20M389.80M315.77M250.92M243.29M
EBITDA194.60M187.10M179.60M159.16M115.99M113.33M
Net Income72.70M68.80M60.80M64.54M52.56M53.60M
Balance Sheet
Total Assets1.28B1.35B1.31B1.20B688.42M674.69M
Cash, Cash Equivalents and Short-Term Investments49.00M59.00M75.50M103.27M88.40M71.15M
Total Debt474.30M469.70M491.80M441.29M161.22M159.39M
Total Liabilities605.60M651.10M679.10M619.50M258.71M247.90M
Stockholders Equity678.80M699.40M634.30M577.13M429.71M426.79M
Cash Flow
Free Cash Flow140.30M125.80M120.90M84.90M87.69M86.47M
Operating Cash Flow143.80M133.70M131.90M91.79M94.88M92.65M
Investing Cash Flow-14.50M-70.40M-140.60M-281.56M-12.18M-10.84M
Financing Cash Flow-172.90M-83.10M-11.30M199.46M-68.68M-93.55M

IPH Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.69
Price Trends
50DMA
3.57
Positive
100DMA
3.58
Positive
200DMA
4.09
Negative
Market Momentum
MACD
-0.02
Negative
RSI
54.90
Neutral
STOCH
50.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IPH, the sentiment is Positive. The current price of 3.69 is above the 20-day moving average (MA) of 3.61, above the 50-day MA of 3.57, and below the 200-day MA of 4.09, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 54.90 is Neutral, neither overbought nor oversold. The STOCH value of 50.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:IPH.

IPH Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
AU$1.15B13.9131.30%5.51%11.64%18.08%
76
Outperform
AU$165.90M18.548.06%4.11%27.05%520.93%
75
Outperform
AU$880.88M12.2610.32%10.58%16.61%3.07%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
AU$325.98M107.7813.37%0.11%24.47%21.28%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:IPH
IPH Ltd.
3.69
-0.84
-18.47%
AU:SIQ
Smartgroup Corporation Ltd
8.67
1.29
17.48%
AU:CUP
Countplus Limited
1.01
0.28
39.20%
AU:KPG
Kelly Partners Group Holdings Ltd.
7.15
-6.13
-46.16%

IPH Ltd. Corporate Events

IPH Sets Date for Release of 2026 Half-Year Financial Results
Jan 18, 2026

IPH Limited has announced that it will release its half-year financial results for the period ended 31 December 2025 on 19 February 2026, followed by a webcast analyst and shareholder briefing the same morning, with a recording to be made available on the company’s website. The advance notice underscores IPH’s ongoing engagement with the market and its investor base, providing stakeholders with clarity on the timing of key financial disclosures and an opportunity to hear management’s commentary on the company’s performance and outlook.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Ltd Reports Lapse of 26,308 Performance Rights
Jan 15, 2026

IPH Ltd has notified the market that 26,308 performance rights (ASX code IPHAA) have lapsed after the conditions attached to those rights were not met or became incapable of being satisfied as at 31 December 2025. The cessation of these conditional rights represents a minor adjustment to the company’s issued capital and reflects the non-fulfilment of performance hurdles under an incentive scheme rather than any change in its core operations.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

Citigroup Entities Exit Substantial Holder Position in IPH Ltd
Dec 29, 2025

Citigroup Global Markets Australia Pty Limited and its related Citi group entities have notified IPH Ltd that they have ceased to be substantial shareholders in the company as of 24 December 2025. The change follows a reduction in relevant interests arising from securities lending arrangements, with Citibank N.A. Sydney Branch and Citigroup Global Markets Limited both decreasing their holdings of IPH ordinary fully paid shares under obligations to return stock lent to counterparties, signaling a withdrawal of Citi’s substantial holder status and potentially altering the composition of IPH’s institutional investor base.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

JPMorgan Ceases to Be Substantial Holder in IPH Ltd
Dec 28, 2025

JPMorgan Chase & Co. and its affiliates have notified IPH Ltd that they have ceased to be a substantial holder in the company, following a series of changes in their relevant interests in IPH’s ordinary shares. The change reflects transactions across multiple JPMorgan entities, including securities lending, investment management activities, principal trading, and rehypothecation under prime brokerage, resulting in their voting power falling below the substantial holding threshold as of 23 December 2025, a move that may slightly alter IPH’s institutional shareholder base and could affect perceptions of its free float and liquidity among investors.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Releases 6m Escrowed Shares Linked to ROBIC Acquisition
Dec 24, 2025

IPH Limited has released 5,961,705 fully paid ordinary shares from voluntary escrow, relating to its acquisition of Canadian IP firm ROBIC completed in December 2023. The company acknowledged that its notice to the ASX regarding the share release was lodged later than required due to an administrative oversight, but stated that its current compliance arrangements remain adequate and that it does not see a need for additional measures, suggesting minimal operational or regulatory impact from the delay for investors and other stakeholders.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Ltd. Updates on Director’s Interest and Performance Rights Acquisition
Dec 10, 2025

IPH Ltd. announced a change in the director’s interest, specifically concerning Andrew Nathaniel Blattman, who holds both direct and indirect interests in the company’s securities. The notice details that there were no changes in the number of shares held, but there was an acquisition of 91,422 performance rights under the company’s Employee Incentive Plan. This update reflects the company’s ongoing commitment to aligning executive interests with shareholder value, potentially impacting stakeholder confidence and the company’s strategic direction.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Limited Director Increases Shareholding
Dec 10, 2025

IPH Limited announced a change in the interest of its director, Katharine Anne Mason, who acquired 14,300 fully paid ordinary shares through an on-market trade, increasing her total holdings to 26,977 shares. This acquisition reflects a significant increase in Mason’s stake in the company, potentially indicating her confidence in the company’s future performance and strategic direction, which may positively impact stakeholder perceptions and market positioning.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$4.04 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Ltd. Director Increases Shareholding
Nov 27, 2025

IPH Ltd. announced a change in the director’s interest, with Vicki Anne Carter acquiring additional shares through an on-market trade. This change reflects an increase in Carter’s indirect interest in the company, potentially indicating confidence in the company’s future performance and strategic direction.

The most recent analyst rating on (AU:IPH) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Limited Announces Director Departure
Nov 21, 2025

IPH Limited has announced the cessation of Jingmin Qian as a director, effective November 20, 2025. The announcement details Qian’s interests in the company, which include holding 25,695 fully paid ordinary shares. This change in directorship may impact the company’s governance structure and could have implications for its strategic direction.

The most recent analyst rating on (AU:IPH) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Limited Successfully Concludes 2025 AGM with All Resolutions Passed
Nov 20, 2025

IPH Limited’s 2025 Annual General Meeting concluded with all resolutions passed by poll, including the re-election of directors and approval of security issues under the equity incentive plan. Although a ‘second strike’ on the FY25 Remuneration Report was avoided, a conditional spill resolution was considered but ultimately not enacted. This outcome reflects stability in IPH’s governance and operational strategies, reinforcing its position in the intellectual property services industry.

The most recent analyst rating on (AU:IPH) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

IPH Limited Navigates Market Challenges with Strategic Initiatives and Improved FY25 Results
Nov 20, 2025

IPH Limited reported a challenging FY25 with a Statutory Net Profit After Tax of $68.8 million, up from $60.8 million the previous year, and an Underlying EBITDA increase of 6.0% to $207.2 million, primarily due to acquisitions in Canada. Despite a decline in share price, the company is addressing market challenges by diversifying revenue sources, enhancing business development, and implementing cost efficiencies. The company declared a final dividend of 19.5 cents per share, reflecting a 4% increase from the prior year. The disruptions in the Canadian Intellectual Property Office have started to abate, and IPH is focusing on expanding into additional jurisdictions and improving operational efficiencies to enhance shareholder returns.

The most recent analyst rating on (AU:IPH) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on IPH Ltd. stock, see the AU:IPH Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 20, 2026